| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0008-6363(99)00144-3 |
| P698 | PubMed publication ID | 10615430 |
| P50 | author | Mutsuki Amano | Q57325206 |
| P2093 | author name string | M Seto | |
| K Kaibuchi | |||
| T Asano | |||
| A Takeshita | |||
| H Shimokawa | |||
| K Egashira | |||
| K Kuwata | |||
| T Kozai | |||
| T Yamawaki | |||
| N Katsumata | |||
| I Ikegaki | |||
| T Kandabashi | |||
| P433 | issue | 4 | |
| P304 | page(s) | 1029-1039 | |
| P577 | publication date | 1999-09-01 | |
| P1433 | published in | Cardiovascular Research | Q4642329 |
| P1476 | title | Rho-kinase-mediated pathway induces enhanced myosin light chain phosphorylations in a swine model of coronary artery spasm | |
| P478 | volume | 43 |
| Q49603114 | Aberrant endoplasmic reticulum stress mediates coronary artery spasm through regulating MLCK/MLC2 pathway |
| Q33815232 | Activation of moesin and adducin by Rho-kinase downstream of Rho. |
| Q41428324 | Activation of muscarinic receptors elicits inotropic responses in ventricular muscle from rats with heart failure through myosin light chain phosphorylation |
| Q47782268 | Acute Coronary Syndromes: The Way Forward From Mechanisms to Precision Treatment |
| Q37071805 | Acute Rho-kinase inhibition improves coronary dysfunction in vivo, in the early diabetic microcirculation |
| Q46293928 | Acute inhibition of Rho-kinase attenuates pulmonary hypertension in patients with congenital heart disease |
| Q58423291 | Age-related RhoA expression in blood vessels of rats |
| Q28366052 | Antianginal effects of hydroxyfasudil, a Rho-kinase inhibitor, in a canine model of effort angina |
| Q46679898 | Antiangiogenic properties of fasudil, a potent Rho-Kinase inhibitor |
| Q35025239 | Bone growth stimulators. New tools for treating bone loss and mending fractures |
| Q34784352 | Ca2+ sensitization and PKC contribute to exercise training-enhanced contractility in porcine collateral-dependent coronary arteries |
| Q36171342 | Cardiovascular effects of a novel potent and highly selective azaindole-based inhibitor of Rho-kinase |
| Q28475580 | Characterization of dysferlin deficient SJL/J mice to assess preclinical drug efficacy: fasudil exacerbates muscle disease phenotype |
| Q94561912 | Coronary Artery Spasm: The Interplay Between Endothelial Dysfunction and Vascular Smooth Muscle Cell Hyperreactivity |
| Q34201543 | Coronary artery spasm: review and update |
| Q34389782 | Current advances in the understanding of coronary vasospasm |
| Q35154446 | Deoxyribonucleic Acid copy number aberrations in vasospastic angina patients using an array comparative genomic hybridization |
| Q46496286 | Differential inhibition by the Rho kinase inhibitor Y-27632 of the increases in contractility and Ca2+ transients induced by endothelin-1 in rabbit ventricular myocytes |
| Q28477728 | Dynamic changes in neurexins' alternative splicing: role of Rho-associated protein kinases and relevance to memory formation |
| Q36528016 | Effect of chronic perinatal hypoxia on the role of rho-kinase in pulmonary artery contraction in newborn lambs |
| Q44200042 | Effects of Rho-kinase inhibitor on vasopressin-induced chronic myocardial damage in rats |
| Q34559604 | Emodin inhibits tonic tension through suppressing PKCδ-mediated inhibition of myosin phosphatase in rat isolated thoracic aorta |
| Q54328359 | Endothelin-1, but not angiotensin II, induces afferent arteriolar myosin diphosphorylation as a potential contributor to prolonged vasoconstriction. |
| Q36589568 | Evaluation of coronary microvascular function in patients with vasospastic angina |
| Q44639046 | Evidence for Protein Kinase C-Mediated Activation of Rho- Kinase in a Porcine Model of Coronary Artery Spasm |
| Q44225230 | Fasudil attenuates interstitial fibrosis in rat kidneys with unilateral ureteral obstruction |
| Q84618098 | Guidelines for Diagnosis and Treatment of Patients With Vasospastic Angina (Coronary Spastic Angina) (JCS 2008) - Digest Version - |
| Q41883941 | Highly sensitive myosin phosphorylation analysis in the renal afferent arteriole |
| Q47959474 | IP3 receptor signaling and endothelial barrier function |
| Q85230588 | Impaired Coronary Vasomotion After Coronary Intervention With Drug-Eluting Stents |
| Q46675968 | In vitro and in vivo assays to analyze the contribution of Rho kinase in angiogenesis |
| Q83179889 | Increased RhoA translocation in aorta of diabetic rats |
| Q37107311 | Increased leukocyte ROCK activity in patients after acute ischemic stroke |
| Q36955621 | Inhibition of ROCK activity allows InlF-mediated invasion and increased virulence of Listeria monocytogenes |
| Q37113619 | Inhibition of Rho-kinase leads to rapid activation of phosphatidylinositol 3-kinase/protein kinase Akt and cardiovascular protection. |
| Q40679163 | Integrin-linked kinase is responsible for Ca2+-independent myosin diphosphorylation and contraction of vascular smooth muscle |
| Q34773995 | Intracellular signalling involved in modulating human endothelial barrier function |
| Q46917562 | Involvement of Rho-kinase in experimental vascular endothelial dysfunction |
| Q43735009 | Involvement of Rho-kinase in vascular remodeling caused by long-term inhibition of nitric oxide synthesis in rats |
| Q24791452 | Involvement of RhoA-mediated Ca2+ sensitization in antigen-induced bronchial smooth muscle hyperresponsiveness in mice |
| Q38207481 | Involvement of myosin regulatory light chain diphosphorylation in sustained vasoconstriction under pathophysiological conditions |
| Q37787547 | Key role of the RhoA/Rho kinase system in pulmonary hypertension |
| Q39204011 | Liposomal fasudil, a rho-kinase inhibitor, for prolonged pulmonary preferential vasodilation in pulmonary arterial hypertension |
| Q44639025 | Long-Term Inhibition of Rho-Kinase Suppresses Neointimal Formation After Stent Implantation in Porcine Coronary Arteries: Involvement of Multiple Mechanisms |
| Q44654278 | Long-Term Treatment With a Specific Rho-Kinase Inhibitor Suppresses Cardiac Allograft Vasculopathy in Mice |
| Q48001723 | Mechanisms of lysophosphatidylcholine-induced demyelination: A primary lipid disrupting myelinopathy |
| Q87899972 | Midostaurin: its odyssey from discovery to approval for treating acute myeloid leukemia and advanced systemic mastocytosis |
| Q41905980 | Myosin regulatory light chain diphosphorylation slows relaxation of arterial smooth muscle |
| Q61937151 | New Antianginal Drugs Still Not Available for Clinical Use |
| Q90292904 | PAR-3 controls endothelial planar polarity and vascular inflammation under laminar flow |
| Q24812464 | Pharmacological reversal of endothelin-1 mediated constriction of the spiral modiolar artery: a potential new treatment for sudden sensorineural hearing loss |
| Q85902375 | Prophylactic intra-arterial administration of fasudil hydrochloride for vasospasm following subarachnoid haemorrhage |
| Q39069181 | Protein Interactions at Endothelial Junctions and Signaling Mechanisms Regulating Endothelial Permeability |
| Q73089650 | Purification and in vitro activity of Rho-associated kinase |
| Q36124892 | ROCKs as therapeutic targets in cardiovascular diseases |
| Q42122310 | Real-time imaging of myosin II regulatory light-chain phosphorylation using a new protein biosensor |
| Q94602978 | Recurrent ST Elevation Myocardial Infarction from Norepinephrine-induced Coronary Vasospasm |
| Q37023057 | Rho kinase inhibition by fasudil ameliorates diabetes-induced microvascular damage |
| Q88022105 | Rho kinase signaling and cardiac physiology |
| Q34133985 | Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells |
| Q45869921 | Rho-kinase as a novel gene therapeutic target in treatment of cold ischemia/reperfusion-induced acute lethal liver injury: effect on hepatocellular NADPH oxidase system |
| Q51043726 | Rho-kinase inhibition prevents the progression of diabetic nephropathy by downregulating hypoxia-inducible factor 1α. |
| Q44304788 | Rho-kinase inhibition with intracoronary fasudil prevents myocardial ischemia in patients with coronary microvascular spasm |
| Q37769931 | Rho-kinase inhibition: a novel therapeutic target for the treatment of cardiovascular diseases. |
| Q28345899 | Rho-kinase inhibitors prevent agonist-induced vasospasm in human internal mammary artery |
| Q41809191 | Rho-kinase-dependent actin turnover and actomyosin disassembly are necessary for mouse spinal neural tube closure. |
| Q44016826 | Rho/Rho-kinase is involved in the synthesis of tissue factor in human monocytes |
| Q37800325 | RhoA, a Possible Target for Treatment of Airway Hyperresponsiveness in Bronchial Asthma |
| Q37586828 | RhoA/Rho-kinase signaling: a therapeutic target in pulmonary hypertension |
| Q42052465 | Role of Rho-kinase in mediating contraction of chicken embryo femoral arteries |
| Q30479005 | Somatic excision demonstrates that c-Jun induces cellular migration and invasion through induction of stem cell factor |
| Q54500332 | Stimulation of norepinephrine transporter function by fasudil, a Rho kinase inhibitor, in cultured bovine adrenal medullary cells. |
| Q37139305 | Substrate specificity and inhibitors of LRRK2, a protein kinase mutated in Parkinson's disease |
| Q35127984 | Targets for pharmacological intervention of endothelial hyperpermeability and barrier function |
| Q39662628 | Testing the promiscuity of commercial kinase inhibitors against the AGC kinase group using a split-luciferase screen |
| Q26774795 | The Function of Rho-Associated Kinases ROCK1 and ROCK2 in the Pathogenesis of Cardiovascular Disease |
| Q33844443 | The Rho-kinase inhibitor HA-1077 suppresses proliferation/migration and induces apoptosis of urothelial cancer cells. |
| Q36364561 | The proximal STAT6 and NF-kappaB sites are responsible for IL-13- and TNF-alpha-induced RhoA transcriptions in human bronchial smooth muscle cells |
| Q35046507 | The role of RhoA and Rho-associated kinase in vascular smooth muscle contraction. |
| Q48218097 | Treatment with low dose fasudil for acute ischemic stroke in chronic hypertension |
| Q28579754 | Upregulation of small GTPase RhoA in the basilar artery from diabetic (mellitus) rats |
| Q84565197 | Vasodilatation produced by fasudil mesylate in vivo and in vitro |
Search more.